All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner

Anticancer Research

Volumn 30, Issue 12, 2010, Pages 4915-4920

  Karsy, Michael ^a   Albert, Ladislau ^a   Tobias, Michael E ^a   Murali, Raj ^a   Jhanwar Uniyal, Meena ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

ATRA; CSC; GBM; MAPK

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOIC ACID;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CONCENTRATION RESPONSE; DOWN REGULATION; GLIOBLASTOMA; NEURAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

APOPTOSIS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIOBLASTOMA; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASTIC STEM CELLS; NEURONS; TRETINOIN; UP-REGULATION;

EID: 78751558930     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kallio M, Sankila R, Jaaskelainen J, Karjalainen S and Hakulinen T: A population-based study on the incidence and survival rates of 3857 glioma patients diagnosed from 1953 to 1984. Cancer 65: 1394-1400, 1991.
2. Ohgaki H and Kleihues P: Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100: 2235-2241, 2009.
3. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM and Hayes DN: Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NFl. Cancer Cell 17: 98-110, 2010.
4. Wang Y, Yang J, Zheng H, Tomasek GJ, Zhang P, McKeever PE, Lee EY and Zhu Y: Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 15: 514-526, 2009.
5. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A: Isolation and characterization of tumorigenie, stem-like neural precursors from human glioblastoma. Cancer Res 64: 7011-7021, 2004.
6. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M and Kornblum HI: Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100: 15178-15183, 2003.
7. Singh SK, Clarke ID, Hide T and Dirks PB: Cancer stem cells in nervous system tumors. Oncogene 23: 7267-7273, 2004.
8. Sanai N, Alvarez-Buylla A and Berger MS: Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-822, 2005.
9. Goodman AB: Retinoid receptors, transporters, and metabolizers as therapeutic targets in late onset Alzheimer disease. J Cell Physiol 209: 598-603, 2006.
10. Kast RE: Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinoma. Cancer Biol Ther 7: 1515-1519, 2008.
11. Loaiza-Bonilla A, Gore SD and Carraway HE: Novel approaches for myelodysplastic syndromes: beyond hypomethylating agents. Curr Opin Hematol 17: 104-109, 2010.
12. Miwako I and Kagechika H: Tamibarotene. Drugs Today (Bare) 43: 563-568, 2007.
13. Brtko J: Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention. Cent Eur J Public Health 15: 3-6, 2007.
14. Haque A, Banik NL and Ray SK: Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res 32: 2203-2209, 2007.
15. Pasquali D, Rossi V, Bellastella G, Bellastella A and Sinisi AA: Natural and synthetic retinoids in prostate cancer. Curr Pharm Des 12: 1923-1929, 2006.
16. Das A, Banik NL and Ray SK: Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem Res 34: 87-101, 2009.
17. Haque A, Das A, Hajiaghamohseni LM, Younger A, Banik NL and Ray SK: Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87 MG cells. Cancer Immunol Immunother 56: 615-625, 2007.
18. Zhang R, Banik NL and Ray SK: Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kipl) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87 MG (PTEN-deficient) cells. Cancer Chemother Pharmacol 62: 407-416, 2008.
19. Defer GL, Adle-Biassette H, Ricolfi F, Martin L, Authier FJ, Chomienne C, Degos L and Degos JD: All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications. J Neurooncol 34: 169-177, 1997.
20. Guan K, Chang H, Rolletschek A and Wobus AM: Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res 305: 171-176, 2001.
21. Gumireddy K, Sutton LN, Phillips PC and Reddy CD: All-transretinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin Cancer Res 9: 4052-4059, 2003.
22. Karmakar S, Banik NL and Ray SK: Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87 OMG xenografts in nude mice. Cancer 112: 596-607, 2008.
23. Zhang R, Banik NL and Ray SK: Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NFkappaB survival signaling in glioblastoma U87 MG cells for induction of apoptosis. Neurochem Res 32: 2194-2202, 2007.
24. Chaichana K, Zamora-Berridi G, Camara-Quintana J and Quinones-Hinojosa A: Neurosphere assays: growth factors and hormone differences in tumor and nontumor studies. Stem Cells 24:2851-2857, 2006.
25. Cordey M, Limacher M, Kobel S, Taylor V and Lutolf MP: Enhancing the reliability and throughput of neurosphere culture on hydrogel microwell arrays. Stem Cells 26: 2586-2594, 2008.
26. Chattopadhyay N, Butters RR and Brown EM: Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells. Brain Res Mol Brain Res 57: 100-108, 2001.